Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Jewish Health
In this trial, the addition of a blood biomarker test is being combined with early LDCT to determine if screening with combination may result in detection of more lung cancer at an earlier stage of disease.The study will also assess if the blood test is able to detect lung cancers in high risk individuals when the LDCT is negative for cancer. There will be health-economic costs included in the final analysis of study data.
Age
50–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Smokers or former smokers
At least 20 pack year history of smoking
Ages 50 - 75
You may not be if
Had a CT scan of chest within last 24 months
History of any cancer within 10 yrs (except skin cancer or cervical cancer)
A serious illness that decreases life expectancy to less than 5 years
Any current use of Oxygen
Uncontrolled congestive heart failure or cardiac arrhythmia that would prevent surgery for a lung lesion
Severe COPD or dyspnea that would prevent lung surgery or stereotactic body radiotherapy
Clareo Health | Lung Cancer Screening Study With Low-dose CT Scan and Blood Biomarker
